Insights

Strategic Partnerships SyntheticGestalt has recently announced a collaboration with Enamine Ltd to advance a joint programme, indicating openness to ecosystem partnerships that can expand their drug discovery capabilities and accelerate commercialization.

Molecule AI Momentum The launch of Molecular AI Models ZAO and KOYA signals an active productization of molecular AI solutions, presenting opportunities to position complementary ML tools, data services, or tailored model development partnerships.

Showcase Footprint Participation and presentations at high-profile AI and semiconductor conferences (NVIDIA GTC, AI Leader's Meetup, CEATEC) demonstrate market visibility and credibility, suggesting outreach strategies focused on enterprise customers seeking advanced generative models.

Growing Revenue With a revenue range of 1–10 million and total funding of 15 million, the company appears to be in a growth phase, making it suitable for upsell of platform licenses, premium support, and expanded research collaboration arrangements.

Tech Stack & Ops Reliance on cloud and collaboration tools (Google Cloud, Firebase, Slack, Notion) indicates opportunities to discuss scalable, secure, integrated solutions, data pipelines, and enterprise-grade deployment for life-science research workflows.

SyntheticGestalt Tech Stack

SyntheticGestalt uses 8 technology products and services including Squarespace, Cookiebot, Firebase, and more. Explore SyntheticGestalt's tech stack below.

Squarespace

Content Management System

Cookie Compliance

Database

Infrastructure As A Service

Notion

Page Builders

Google

Search Engines

Slack

Software Framework

SyntheticGestalt Email Formats	Example	Percentage
F.Last@syntheticgestalt.com	J.Doe@syntheticgestalt.com	100%

SyntheticGestalt Email Formats

Example

Percentage

F.Last@syntheticgestalt.com

J.Doe@syntheticgestalt.com

100%

Frequently Asked Questions

What is SyntheticGestalt's official website and social media links?

SyntheticGestalt's official website is syntheticgestalt.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does SyntheticGestalt generate?

As of August 2026, SyntheticGestalt's annual revenue is estimated to be $1M - $10M.

What is SyntheticGestalt's SIC code and NAICS code?

SyntheticGestalt's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does SyntheticGestalt have currently?

As of August 2026, SyntheticGestalt has approximately 19 employees across 2 continents, including Asia and Europe. Key team members include Chief Technology Officer: K. K., Chief Financial Officer: M. K. and Vp Of Ai: P. G. Explore SyntheticGestalt's employee directory with LeadIQ.

What industry does SyntheticGestalt belong to?

SyntheticGestalt operates in the Biotechnology Research industry.

What technology does SyntheticGestalt use?

SyntheticGestalt's tech stack includes Squarespace, Cookiebot, Firebase, Google Workspace, Google Cloud, Notion, Google and Slack.

What is SyntheticGestalt's email format?

SyntheticGestalt's email format typically follows the pattern of F.Last@syntheticgestalt.com. Find more SyntheticGestalt email formats with LeadIQ.

How much funding has SyntheticGestalt raised to date?

As of August 2026, SyntheticGestalt has raised $15M in funding. The last funding round occurred on Oct 08, 2025 for $1M.

When was SyntheticGestalt founded?

SyntheticGestalt was founded in 2018.

SyntheticGestalt

Q: What is SyntheticGestalt's official website and social media links?

SyntheticGestalt's official website is syntheticgestalt.com. SyntheticGestalt has social profiles on LinkedIn.

Q: How many employees does SyntheticGestalt have currently?

SyntheticGestalt has approximately 19 employees.

Q: What technology does SyntheticGestalt use?

SyntheticGestalt's tech stack includes Kaggle, Google Domains, Node.js, X-Content-Type-Options, HTTP/3.

Q: What is SyntheticGestalt's NAICS code?

SyntheticGestalt's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchEngland, United Kingdom11-50 Employees

SyntheticGestalt operates in biotechnology research, developing machine learning models to support drug discovery and software that facilitates and automates life-sciences research workflows. The company focuses on molecular generative modeling and related tools to help researchers design and evaluate compounds more efficiently. A notable development is GENIAC Phase 3 milestones, which were presented to the industry at AI Leader's Meetup Spring in 2026.

Based in London, England, SyntheticGestalt is a small to mid-sized team serving researchers in the life sciences sector seeking advanced computational approaches to accelerate discovery. Its activity and public appearances at major technology conferences reflect its position in the AI-enabled biotechnology space.

Insights

Similar companies to SyntheticGestalt

Informa TechTarget

VMblog